MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0233343
Avery Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.83 Cr
▲ 42% YoY
Net loss · FY 2025
₹4.74 Cr
Net margin -258.8%
EBITDA · FY 2025
-₹2.65 Cr
EBITDA margin -144.8%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹71.45 Lakh
Issued & subscribed
Open charges
₹3 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
41
Provident fund records
About Avery Pharmaceuticals Private Limited
Data last updated:
Avery Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Arrow Greentech Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC295476. Its GSTIN is 27AAPCA6309L1Z8 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹71.45 Lakh. It is led by directors Shilpan Pravin Patel and Neil Shilpan Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 159 Mittal Industrial Estate Sanjay Building No 5/B Marol Naka Andheri (E), Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net loss of ₹4.74 Cr (net margin -258.8%) and EBITDA of -₹2.65 Cr (EBITDA margin -144.8%).
The company has about 41 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Avery Pharmaceuticals. As per MCA filings, the company has open charges of ₹3 Cr on record.
Avery Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0233343). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website averypharma.co.in.
Company details
CIN U74999MH2017PTC295476
Registration Number 295476
Incorporation Date 29 May 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Arrow Greentech Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0233343
Recognitions & Rankings of Avery Pharmaceuticals
Contact details
Avery Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is averypharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address159 Mittal Industrial Estate Sanjay Building No 5/B Marol Naka Andheri (E), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avery Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Avery Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Avery Pharmaceuticals operates one associated brand: Avery Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A specialty pharmaceutical company focusing on innovative drug delivery systems and patient care enhancements through Mouth Dissolving Strips technology. | averypharma.co.in |
Business activity
The main business activities of Avery Pharmaceuticals are manufacturing and financial and insurance service. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other financial activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Avery Pharmaceuticals Private Limited, buy the company report.
Financials of Avery Pharmaceuticals Private Limited
FY 2025 filings availableAvery Pharmaceuticals Private Limited reported revenue of ₹1.83 Cr (up 42% YoY) for FY 2025.
Revenue · FY 2025
₹1.83 Cr ▲ 42%
Net loss · FY 2025
₹4.74 Cr margin -258.8%
EBITDA · FY 2025
-₹2.65 Cr margin -144.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 8%
5 years · compounded
▼ 18%
Revenue rose 42% in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -144.8% | ||||
| Net Profit Margin | -258.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avery Pharmaceuticals Private Limited, buy the company report.
Board of directors of Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpan Pravin Patel Also directs: Arrow Greentech Limited, Grace Paper Industries Pvt Ltd, Arrow Agri-Tech Private Limited and 4 more | Director | 29 May 2017 | 9 Years 5 Months | Current |
| Neil Shilpan Patel Also directs: Arrow Greentech Limited, Arrow Agri-Tech Private Limited, Arrow Business Advisory Private Limited and 3 more | Director | 29 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Avery Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vishnu Poly-Chems Private Limited | ₹1.84 Cr (FY 2019) | -15.0% | Solapur, Maharashtra, India | |||
| Avery Pharmaceuticals Private Limitedthis company | ₹1.83 Cr (FY 2025) | -₹4.74 Cr | -258.8% | 42.0% | 41 | Mumbai, Maharashtra, India |
| Suzikem Drugs Private Limited | ₹1.83 Cr (FY 2024) | -29.0% | Hyderabad, Telangana, India | |||
| Nectar Laboratories Private Limited | ₹1.83 Cr (FY 2025) | -76.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Avery Pharmaceuticals Private Limited, buy the company report.
Auditor
Avery Pharmaceuticals Private Limited is audited by R. A. Kuwadia & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. A. Kuwadia & Co. | FY 2023 | 105487W |
Shareholding
The shareholding of Avery Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avery Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2019 | 100270587 | Others | ₹3 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Avery Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Avery Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2020 and 2021, listing 13 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Thermolab Scientific Equipments Private Limited | |||
| an individual supplier | |||
| Clean Air Engineers | |||
| an individual supplier |
To see the full MSME payment records of Avery Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Avery Pharmaceuticals Private Limited has a workforce of 41 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
41
Active EPFO establishments
1
Employee growth
28.12%
GST
Avery Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA6309L1Z8 | Maharashtra | Active | 25 Aug 2017 |
| 24AAPCA6309L1ZE | Gujarat | Active | 13 Jun 2018 |
To see the full GST registrations and return filing status of Avery Pharmaceuticals Private Limited, buy the company report.
Recent activity
Avery Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Neil Shilpan Patel was appointed as Director on 29 May 2017.
AGM
Avery Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Avery Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100270587 was registered on 30 May 2019.
Appointed
Neil Shilpan Patel was appointed as Director.
Appointed
Shilpan Pravin Patel was appointed as Director.
Incorporation
29 May 2017
Avery Pharmaceuticals Private Limited was registered on 29 May 2017 with Roc Mumbai & aged 9 years 5 months as per MCA records.
Frequently asked questions
Avery Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999MH2017PTC295476.
Avery Pharmaceuticals has 2 current directors:
- Shilpan Pravin Patel - Director
- Neil Shilpan Patel - Director
The latest financial statements of Avery Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Avery Pharmaceuticals is 27AAPCA6309L1Z8, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAPCA6309L1ZE (Gujarat).
The CIN (Corporate Identification Number) of Avery Pharmaceuticals is U74999MH2017PTC295476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avery Pharmaceuticals was incorporated on 29 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Avery Pharmaceuticals by revenue are Vishnu Poly-Chems Private Limited, Suzikem Drugs Private Limited, Nectar Laboratories Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Neil Shilpan Patel was appointed as Director on 29 May 2017. Shilpan Pravin Patel was appointed as Director on 29 May 2017.
Yes, Avery Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0233343).
Avery Pharmaceuticals has 3 MSME Form 1 returns on record between 2020 and 2021, listing 13 overdue payments to 8 micro and small suppliers. The latest return was filed on 13 May 2021.
Avery Pharmaceuticals can be reached through the website averypharma.co.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Avery Pharmaceuticals is at 159 Mittal Industrial Estate Sanjay Building No 5B Marol Naka Andheri E, Mumbai, Maharashtra, India – 400059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages